Annotation Detail

Information
Associated Genes
RUNX1
Associated Variants
RUNX1 MUTATION
RUNX1 MUTATION
Associated Disease
acute myeloid leukemia
Source Database
CIViC Evidence
Description
In 878 non-APL patients with AML, those who had mutations in RUNX1 (N=53) had higher rates of refractory disease than those without (30% versus 19%; P = 0.047).
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/429
Gene URL
https://civic.genome.wustl.edu/links/genes/43
Variant URL
https://civic.genome.wustl.edu/links/variants/155
Rating
4
Evidence Type
Prognostic
Disease
Acute Myeloid Leukemia
Evidence Direction
Supports
Evidence Level
B
Clinical Significance
Poor Outcome
Pubmed
21343560
Drugs